12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Nanotechnology Inspired Tools for Mitochondrial Dysfunction Related Diseases

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mitochondrial dysfunctions are recognized as major factors for various diseases including cancer, cardiovascular diseases, diabetes, neurological disorders, and a group of diseases so called “mitochondrial dysfunction related diseases”. One of the major hurdles to gain therapeutic efficiency in diseases where the targets are located in the mitochondria is the accessibility of the targets in this compartmentalized organelle that imposes barriers towards internalization of ions and molecules. Over the time, different tools and techniques were developed to improve therapeutic index for mitochondria acting drugs. Nanotechnology has unfolded as one of the logical and encouraging tools for delivery of therapeutics in controlled and targeted manner simultaneously reducing side effects from drug overdose. Tailor-made nanomedicine based therapeutics can be an excellent tool in the toolbox for diseases associated with mitochondrial dysfunctions. In this review, we present an extensive coverage of possible therapeutic targets in different compartments of mitochondria for cancer, cardiovascular, and mitochondrial dysfunction related diseases.

          Graphical abstract

          Related collections

          Author and article information

          Journal
          8710523
          21484
          Adv Drug Deliv Rev
          Adv. Drug Deliv. Rev.
          Advanced drug delivery reviews
          0169-409X
          1872-8294
          2 February 2016
          09 January 2016
          1 April 2016
          01 April 2017
          : 99
          : Pt A
          : 52-69
          Affiliations
          [a ]NanoTherapeutics Research Laboratory, Department of Chemistry, University of Georgia, Athens, GA 30602
          [b ]Partikula LLC, Sunrise, FL 33326
          Author notes
          [* ]To whom correspondence should be addressed. Shanta Dhar, NanoTherapeutics Research Laboratory, Department of Chemistry, University of Georgia, Athens, GA 30602, Telephone: 706-542-1012, Fax: 706-542-9454, shanta@ 123456uga.edu
          Article
          PMC4798867 PMC4798867 4798867 nihpa750664
          10.1016/j.addr.2015.12.024
          4798867
          26776231
          1f242ff5-bdf3-49d3-8b30-07d1819885f4
          History
          Categories
          Article

          Comments

          Comment on this article